Triple bone labeling of canine mandibles

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Triple bone labeling of canine mandibles. / Pinholt, E M; Kwon, P H.

In: Oral surgery, oral medicine, and oral pathology, Vol. 70, No. 4, 01.10.1990, p. 401-5.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pinholt, EM & Kwon, PH 1990, 'Triple bone labeling of canine mandibles', Oral surgery, oral medicine, and oral pathology, vol. 70, no. 4, pp. 401-5.

APA

Pinholt, E. M., & Kwon, P. H. (1990). Triple bone labeling of canine mandibles. Oral surgery, oral medicine, and oral pathology, 70(4), 401-5.

Vancouver

Pinholt EM, Kwon PH. Triple bone labeling of canine mandibles. Oral surgery, oral medicine, and oral pathology. 1990 Oct 1;70(4):401-5.

Author

Pinholt, E M ; Kwon, P H. / Triple bone labeling of canine mandibles. In: Oral surgery, oral medicine, and oral pathology. 1990 ; Vol. 70, No. 4. pp. 401-5.

Bibtex

@article{27efa942b12a4901aeccda8c929273d7,
title = "Triple bone labeling of canine mandibles",
abstract = "Fluorescence microscopy was used for evaluation of new bone formation in 16 canine mandibles augmented with hydroxylapatite (HA) granules. Three fluorochromes were injected at different time intervals during therapeutic radiation treatment. Oxytetracycline, DCAF, and alizarin-complexone were given intravenously to mark the bone level at these times, respectively. Oxytetracycline, which defined the baseline of bone at implantation of HA, was detectable in 42% of animals that were irradiated and in no animal of the nonirradiated control group. The marker DCAF, designating levels of bone at the start of radiation, was demonstrated in 92% of irradiated animals, and in 75% of animals in the control group. The uptake of alizarin-complexone determined the level of bone found at the end of irradiation. This marker was demonstrated in 50% of the dogs irradiated and in 75% of the control dogs. Bony trabeculae were found between and at the surface of the HA granules. New generation of bone directly on the HA granule and in the surrounding haversian systems as part of normal bone turnover was demonstrated to take place more than 5 months after implantation of HA.",
keywords = "Alveolar Bone Loss, Alveolar Process, Alveolar Ridge Augmentation, Animals, Anthraquinones, Dogs, Durapatite, Fluoresceins, Fluorescent Dyes, Hydroxyapatites, Male, Mandible, Microscopy, Fluorescence, Osteogenesis, Oxytetracycline",
author = "Pinholt, {E M} and Kwon, {P H}",
year = "1990",
month = oct,
day = "1",
language = "English",
volume = "70",
pages = "401--5",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Triple bone labeling of canine mandibles

AU - Pinholt, E M

AU - Kwon, P H

PY - 1990/10/1

Y1 - 1990/10/1

N2 - Fluorescence microscopy was used for evaluation of new bone formation in 16 canine mandibles augmented with hydroxylapatite (HA) granules. Three fluorochromes were injected at different time intervals during therapeutic radiation treatment. Oxytetracycline, DCAF, and alizarin-complexone were given intravenously to mark the bone level at these times, respectively. Oxytetracycline, which defined the baseline of bone at implantation of HA, was detectable in 42% of animals that were irradiated and in no animal of the nonirradiated control group. The marker DCAF, designating levels of bone at the start of radiation, was demonstrated in 92% of irradiated animals, and in 75% of animals in the control group. The uptake of alizarin-complexone determined the level of bone found at the end of irradiation. This marker was demonstrated in 50% of the dogs irradiated and in 75% of the control dogs. Bony trabeculae were found between and at the surface of the HA granules. New generation of bone directly on the HA granule and in the surrounding haversian systems as part of normal bone turnover was demonstrated to take place more than 5 months after implantation of HA.

AB - Fluorescence microscopy was used for evaluation of new bone formation in 16 canine mandibles augmented with hydroxylapatite (HA) granules. Three fluorochromes were injected at different time intervals during therapeutic radiation treatment. Oxytetracycline, DCAF, and alizarin-complexone were given intravenously to mark the bone level at these times, respectively. Oxytetracycline, which defined the baseline of bone at implantation of HA, was detectable in 42% of animals that were irradiated and in no animal of the nonirradiated control group. The marker DCAF, designating levels of bone at the start of radiation, was demonstrated in 92% of irradiated animals, and in 75% of animals in the control group. The uptake of alizarin-complexone determined the level of bone found at the end of irradiation. This marker was demonstrated in 50% of the dogs irradiated and in 75% of the control dogs. Bony trabeculae were found between and at the surface of the HA granules. New generation of bone directly on the HA granule and in the surrounding haversian systems as part of normal bone turnover was demonstrated to take place more than 5 months after implantation of HA.

KW - Alveolar Bone Loss

KW - Alveolar Process

KW - Alveolar Ridge Augmentation

KW - Animals

KW - Anthraquinones

KW - Dogs

KW - Durapatite

KW - Fluoresceins

KW - Fluorescent Dyes

KW - Hydroxyapatites

KW - Male

KW - Mandible

KW - Microscopy, Fluorescence

KW - Osteogenesis

KW - Oxytetracycline

M3 - Journal article

C2 - 2170892

VL - 70

SP - 401

EP - 405

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 4

ER -

ID: 33984980